Pursuant to Regulation 24A of SEBI (LODR) Regulations, 2015, enclosed is the copy of Annual Secretarial Compliance Report for the year ended March 31, 2025.
VALIANTLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Valiant Laboratories has submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2025, as required under SEBI's listing rules. The report, prepared by practising company secretary Sunil M. Dedhia & Co., confirms that the company has complied with all applicable SEBI regulations covering listing obligations, insider trading, related party transactions, and corporate governance norms. No deviations, penalties, or actions by SEBI or stock exchanges were reported during the review period. The statutory auditor did not resign during the year, and all required policies and disclosures were found to be in order.
This is a routine annual compliance filing with no negative findings, which signals clean corporate governance and no regulatory trouble for shareholders. It is unlikely to have any material impact on the stock price.